Alpay, B. Et Al. NSAIDs, CGRP Monoclonal Antibodies, and COVID-19. 2023. In Headache Disorders in Pandemic Conditions , Springer Cham, cham, 191-201.

Alpay, B., ÇİMEN, B., & SARA, M. Y., (2023). NSAIDs, CGRP Monoclonal Antibodies, and COVID-19. Headache Disorders in Pandemic Conditions (pp.191-201), cham: Springer Cham.

Alpay, Berkay, BARIŞCAN ÇİMEN, And MEHMET YILDIRIM SARA. "NSAIDs, CGRP Monoclonal Antibodies, and COVID-19." In Headache Disorders in Pandemic Conditions , 191-201. cham: Springer Cham, 2023

Alpay, Berkay Et Al. "NSAIDs, CGRP Monoclonal Antibodies, and COVID-19." Headache Disorders in Pandemic Conditions , Springer Cham, 2023, pp.191-201.

Alpay, B. ÇİMEN, B. And SARA, M. Y. (2023) "NSAIDs, CGRP Monoclonal Antibodies, and COVID-19", Headache Disorders in Pandemic Conditions . cham: Springer Cham.

@bookchapter{bookchapter, author ={Berkay Alpay Et Al. }, chaptertitle={NSAIDs, CGRP Monoclonal Antibodies, and COVID-19}, booktitle={ Headache Disorders in Pandemic Conditions}, publisher={Springer Cham}, city={cham},year={2023} }